Amicus Therapeutics Inc. News
Amicus Therapeutics Stock Rises; Sells Unit Stake in SPAC Deal
Amicus is selling a stake in its gene-therapy unit to ARYA Sciences Acquisition IV, a special purpose acquisition company sponsored by Perceptive Advisors.
HubSpot, Twitter, Sonos: Latest Upgrades and Downgrades
TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Estee Lauder, Twitter and Uber.
Amicus Reports Disappointing Tests Results for Pompe Disease Drug
Amicus tanks as analysts downgrade it after the company reported disappointing test results for its Pompe disease drug.
FedEx, Funko, Amicus Therapeutics: 'Mad Money' Lightning Round
Jim Cramer takes a look at FedEx, Funko, Amicus Therapeutics, Turning Point Brands, Sirius XM Radio, and more.
Groupon, Wix.com, Las Vegas Sands: 'Mad Money' Lightning Round
Jim Cramer takes a look at Groupon, Wix.com, Las Vegas Sands, Paycom Software, Bojangles, FedEx, Amicus Therapeutics, Discovery Communications.
Alkermes wins quick reversal from FDA on antidepressant drug
Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.
Portola Shares Lower After Pricing Stock Offering - Biotech Movers
The South San Francisco, Calif.-based firm said Sept. 12 it had priced its underwritten public offering of 6.35 million shares at $55 apiece.
Teligent Shares Rise on FDA Approval for Erythromycin Topical Gel
Teligent, FibroGen and Amicus Therapeutics were among the biotech stock movers in premarket trading on July 21.
Tips for Retirees to Deal with Falling Stocks and Bonds
The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.
Alphabet CEO Pichai Continues to Sound Alarm About the Economy
The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.